What Happened

Forus, a company building an AI network to connect doctors, pharmacies, payers, and biopharma companies, raised $150 million in Series C financing at a $3 billion valuation. The round was led by Bain Capital Ventures, with participation from all existing institutional investors including Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Vast Ventures, and SV Angel. Total funding now exceeds $300 million.

The company's platform is used by providers across all 50 U.S. states, covering 85% of residential ZIP codes. More than one-third of providers in its first launched specialty have adopted the platform, with double-digit percentages in several other specialties.

Who Is Affected

Forus's platform directly impacts providers, patients, and biopharma companies. Providers use the AI agents embedded in their workflows to manage insurance approvals, financial assistance, and supply chain coordination. Patients benefit from faster treatment initiation—approvals now come back in less than two days, and patients start treatment within one to two weeks. Biopharma companies, including 9 of the top 15 global biopharma firms, use the platform for research, commercialization, and launch of new medicines.

Market Impact

• Forus is targeting a major inefficiency in specialty medicine: one in three patients prescribed a high-cost or complex medication never receives a first dose. The platform reduces administrative friction and makes treatment pathways more predictable.
• The company plans to expand its AI network across the broader biopharma lifecycle, from clinical development through patient access, creating new opportunities for vendors in sales, CRM, and data infrastructure.
• With a $3 billion valuation and $300 million total funding, Forus is positioned as a leading AI scale-up in healthcare, likely to drive increased competition and demand for enterprise tools.

What to Watch

Forus will use the new funding to expand into additional specialties and care settings, extend AI agent capabilities across the treatment process, and increase investment in its team. The company's goal is to put its platform in every doctor's office in the country. Sales reps should monitor Forus's hiring and platform expansion as signals for new procurement needs in CRM, data analytics, and sales enablement.

Related coverage

• Fintech Félix raises $200M equity and debt to expand AI financial services in Latin America
• Split Pay raises $125M across Series A and B for paycheck-timing fintech
• Archy Raises $50M Series C for AI Dental Practice Management Platform
• Clay raises $115M Series D at $7.1B valuation led by Wellington Management